3327 Survival outcomes in patients (pts) with advanced (adv) melanoma (MEL) with brain metastases treated with 1st-line (1L) ipilimumab (IPI). (September 2015) - Patt, D.; Rao, S.; Espirito, J.; Wilson, T.; Fox, P.